Eledon Pharmaceuticals Stock Quote ELDN - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.06

Bid

2.01

Ask

2.09

Volume

81,544

2.00 Day's Range 2.08

1.07 52 Week Range 2.95

Market Cap

49.606M

Previous Close

2.02

Open

2.05

Last Trade

2500

2.01

(formt)

Last Trade Time

Financial Volume

$ 167,441

VWAP

2.0534

Average Volume (3m)

90,426

Shares Outstanding

24,198,130

Dividend Yield

PE Ratio

-1.23

Earnings Per Share (EPS)

-1.67

Revenue

Net Profit

-40.33M

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eledon.com

Headquarters

Dover, Delaware, USA

Founded

1970

Eledon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELDN. The last closing price for Eledon Pharmaceuticals was $2.02. Over the last year, Eledon Pharmaceuticals shares have traded in a share price range of $ 1.07 to $ 2.95.

Eledon Pharmaceuticals currently has 24,198,130 shares outstanding. The market capitalization of Eledon Pharmaceuticals is $49.61 million. Eledon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.23.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney rejection Tegoprubart used as a component of the immunosuppressive treatment regimen following...

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

IRVINE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the enrollment of the 12th participant on March 23, 2024, in the...

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Historic kidney xenotransplantation procedure conducted at Massachusetts General Hospital Tegoprubart administration has now been used investigationally to prevent rejection in both kidney and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.05	-2.36966824645	2.11	2.2	1.77	217962	1.97803152	CS
4	-0.04	-1.90476190476	2.1	2.2	1.52	123613	1.88801367	CS
12	0.25	13.8121546961	1.81	2.23	1.5199	90426	1.87240044	CS
26	0.61	42.0689655172	1.45	2.23	1.07	90219	1.68335875	CS
52	-0.21	-9.25110132159	2.27	2.95	1.07	114041	1.84542928	CS
156	-8.58	-80.6390977444	10.64	11.69	1.07	71815	3.22414708	CS
260	-13.74	-86.9620253165	15.8	22.91	1.07	71243	4.20606202	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M